These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6801989)

  • 1. Interstitial and hemorrhagic pneumonitis induced by mycobacterial trehalose dimycolate.
    Seggev J; Goren MB; Carr RI; Kirkpatrick CH
    Am J Pathol; 1982 Mar; 106(3):348-55. PubMed ID: 6801989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pathogenesis of trehalose dimycolate-induced hemorrhagic pneumonia induced in mice as animal model of human alveolar hemorrhagic syndrome].
    Sakamoto Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Feb; 27(2):206-13. PubMed ID: 2787442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis.
    Takimoto H; Maruyama H; Shimada KI; Yakabe R; Yano I; Kumazawa Y
    Clin Exp Immunol; 2006 Apr; 144(1):134-41. PubMed ID: 16542375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids.
    Behling CA; Perez RL; Kidd MR; Staton GW; Hunter RL
    Ann Clin Lab Sci; 1993; 23(4):256-66. PubMed ID: 8373130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterial sulfolipid shows a virulence by inhibiting cord factor induced granuloma formation and TNF-alpha release.
    Okamoto Y; Fujita Y; Naka T; Hirai M; Tomiyasu I; Yano I
    Microb Pathog; 2006 Jun; 40(6):245-53. PubMed ID: 16626929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary TCR γδ T cells induce the early inflammation of granuloma formation by a glycolipid trehalose 6,6'-dimycolate (TDM) isolated from Mycobacterium tuberculosis.
    Saitoh T; Yano I; Kumazawa Y; Takimoto H
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):815-23. PubMed ID: 22963130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of iv mycobacterial cell wall skeleton and cell wall skeleton combined with trehalose dimycolate.
    Vosika GJ; Gray GR
    Cancer Treat Rep; 1983 Sep; 67(9):785-90. PubMed ID: 6883355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of interstitial pneumonitis induced by trehalose dimycolate. II. Reserpine prevents formation of lesions.
    Seggev JS; Kirkpatrick CH; Goren MB
    Am Rev Respir Dis; 1984 May; 129(5):840-3. PubMed ID: 6721282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypes of infiltrating cells in trehalose dimycolate-induced interstitial pneumonitis.
    Sakamoto Y; Goren MB; Kirkpatrick CH
    Infect Immun; 1989 Jul; 57(7):2098-106. PubMed ID: 2731985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between augmented resistance to influenza virus infection and histological changes in lung of mice treated with trehalose-6,6'-dimycolate.
    Azuma M; Sazaki K; Nishikawa Y; Takahashi T; Shimoda A; Suzutani T; Yoshida I; Sakuma T; Nakaya K
    J Biol Response Mod; 1988 Oct; 7(5):473-82. PubMed ID: 2460592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
    Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
    Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of mycoloyl glycolipids derived from Rhodococcus sp. 4306.
    Ueda S; Fujiwara N; Naka T; Sakaguchi I; Ozeki Y; Yano I; Kasama T; Kobayashi K
    Microb Pathog; 2001 Feb; 30(2):91-9. PubMed ID: 11162189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterial trehalose 6,6'-dimycolate preferentially induces type 1 helper T cell responses through signal transducer and activator of transcription 4 protein.
    Oiso R; Fujiwara N; Yamagami H; Maeda S; Matsumoto S; Nakamura S; Oshitani N; Matsumoto T; Arakawa T; Kobayashi K
    Microb Pathog; 2005; 39(1-2):35-43. PubMed ID: 15967629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate.
    Borders CW; Courtney A; Ronen K; Pilar Laborde-Lahoz M; Guidry TV; Hwang SA; Olsen M; Hunter RL; Hollmann TJ; Wetsel RA; Actor JK
    Scand J Immunol; 2005 Aug; 62(2):123-30. PubMed ID: 16101818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of intravenous mycobacterial cell wall skeleton and trehalose dimycolate attached to oil droplets.
    Vosika G; Giddings C; Gray GR
    J Biol Response Mod; 1984 Dec; 3(6):620-6. PubMed ID: 6512562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo and in vitro effect of trehalose dimycolate on tumoricidal activity of peritoneal macrophages from rats].
    Reisser D; Jeannin JF; Martin F
    C R Acad Sci III; 1984; 298(7):181-3. PubMed ID: 6424900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trehalose 6,6-Dimycolate from Mycobacterium tuberculosis Induces Hypercoagulation.
    Donnachie E; Fedotova EP; Hwang SA
    Am J Pathol; 2016 May; 186(5):1221-33. PubMed ID: 26968340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of trehalose dimycolate-induced interstitial pneumonitis. IV. Evidence against roles for immunoglobulins and the complement system.
    Seggev JS; Goren MB; Carr RI; Rubenstein E; Kirkpatrick CH
    Exp Lung Res; 1988; 14(4):431-44. PubMed ID: 3061788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of trehalose dimycolate-induced interstitial pneumonitis. III. Evidence for a role for T lymphocytes.
    Seggev JS; Goren MB; Kirkpatrick CH
    Cell Immunol; 1984 May; 85(2):428-35. PubMed ID: 6609001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice.
    Fujita Y; Okamoto Y; Uenishi Y; Sunagawa M; Uchiyama T; Yano I
    Microb Pathog; 2007 Jul; 43(1):10-21. PubMed ID: 17434713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.